Novel bioactive composite bone cements based on the β-tricalcium phosphate-monocalcium phosphate monohydrate composite cement system

Acta Biomaterialia

Volumn 5, Issue 4, 2009, Pages 1253-1264

  Huan, Zhiguang ^a,b   Chang, Jiang ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Brushite; Calcium phosphate cement; Cytotoxicity; In vitro test; Silicate

Indexed keywords

BONE; BONE CEMENT; CALCIUM PHOSPHATE; CALCIUM SILICATE; CEMENTS; COMPRESSIVE STRENGTH; SETTING; SILICATES;

BIOACTIVE COMPOSITES; BRUSHITE; BRUSHITE CEMENT; CALCIUM PHOSPHATE CEMENT; CEMENT-BASED; COMPOSITE BONE CEMENTS; IN-VITRO TESTS; MONOCALCIUM PHOSPHATES; TRI-CALCIUM PHOSPHATES; Β-TCP;

TRANSMISSION CONTROL PROTOCOL;

BONE CEMENT; CALCIUM DERIVATIVE; CALCIUM PHOSPHATE; CALCIUM PHOSPHATE DIBASIC; MONOCALCIUM PHOSPHATE MONOHYDRATE; PHOSPHATE BUFFERED SALINE; SILICON DERIVATIVE; TRICALCIUM SILICATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIODEGRADATION; BODY FLUID; BONE MARROW CELL; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; IN VITRO STUDY; MATERIALS TESTING; MECHANICAL STRESS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; SIMULATION; STROMA CELL; TIME;

EID: 64249134710     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.10.006     Document Type: Article

References (53)

1. Constanz B.R., Ison I.C., Fulmer M., Poser R.D., and Smith S.T. Skeletal repair by in situ formation of the mineral phase of bone. Science 267 (1995) 1796-1799
2. Schildhauer T.A., Bennett A.P., Wright T.M., Lane J.M., and O'Leary P.F. Intravertebral body reconstruction with an injectable in situ-setting carbonated apatite: biomechanical evaluation of a minimally invasive technique. J Orthop Res 1 (1999) 67-72
3. Li Y.W., Leong J.C.Y., Lu W.W., Luk K.D.K., Cheung K.M.C., and Chiu K.Y. A novel injectable bioactive bone cement for spinal surgery: a developmental and preclinical study. J Biomed Mater Res 52 (2000) 164-170
4. Lidgren L. A composition for an injectable bone mineral substitute material. PCT Int Appl WO 2002005861 A1, 2002.
5. Letmaitre J., Mirtchi A., and Mortier A. Calcium phosphate cements for medical use: state of the art and perspectives of development. Silic Ind 10 (1987) 141-146
6. Grover L.M., Gbureck U., Wright A.J., Tremayne M., and Barralet J.E. Biologically mediated resorption of brushite cement in vitro. Biomaterials 27 (2006) 2178-2185
7. Theiss F., Apelt D., Brand B., Kutter A., Zlinszky K., Bohner M., et al. Biocompatibility and resorption of a brushite calcium phosphate cement. Biomaterials 26 (2005) 4383-4394
8. Charriere E., Terrazzoni S., Pittet C., Mordasini P., Dutoit M., Lemaitre J., et al. Mechanical characterization of brushite and hydroxyapatite cements. Biomaterials 22 (2001) 2937-2945
9. Gbureck U., Grolms O., Barralet J.E., Grover L.M., and Thull R. Mechanical activation and cement formation of β-tricalcium phosphate. Biomaterials 24 (2003) 4123-4131
10. Xia Z., Grover L.M., Huang Y., Adamopoulos I.E., Gbureck U., Triffitt J.T., et al. In vitro biodegradation of three brushite calcium phosphate cements by a macrophage cell-line. Biomaterials 27 (2006) 4557-4565
11. Grover L.M., Gbureck U., Young A.M., Wright A.J., and Barralet J.E. Temperature dependent setting kinetics and mechanical properties of β-TCP-pyrophosphoric acid bone cement. J Mater Chem 15 (2005) 4955-4962
12. Marino F.T., Mastio J., Rueda C., Blanco L., and Cabarcos E.L. Increase of the final setting time of the brushite cement by using chondroitin 4-sulfate and silica gel. J Mater Sci Mater Med 18 (2007) 1195-1201
13. Ooms E.M., Wolke J.G.C., Heuvel M.T., Jeschke B., and Jansen J.A. Histological evaluation of the bone response to calcium phosphate cement implanted in cortical bone. Biomaterials 24 (2003) 989-1000
14. Curran J.M., Gallagher J.A., and Hunt J.A. The inflammatory of biphasic calcium phosphate granules in osteoblast/macrophage co-culture. Biomaterials 26 (2005) 5313-5320
15. Kokubo T., Kushiyani M., Ebisawa Y., Kitsugi, Kotani S., Oura K., et al. Apatite formation on bioactive ceramics in body environment. In: Oonishi, Aoki H., and Sawai K. (Eds). Bioceramics (1988), Ishiyaku EuroAmerica, Tokyo 157-162
16. Suominen E., Aho A.J., Vedel E., Kangasniemi I., Uusipaikka E., and Yli-Urpo A. Subchondral bone and cartilage repair with bioactive glasses, hydroxyapatite, and hydroxyapatite-glass composite. J Biomed Mater Res 32 (1996) 543-551
17. Kobayashi M., Nakamura T., Tamura J., Kokubo T., and Kikutani T. Bioactive bone cement: comparison of AW-GC filler with hydroxyapatite and β-TCP fillers on the mechanical and biological properties. J Biomed Mater Res 37 (1997) 301-313
18. Kobayashi M., Nakamura T., Okada Y., Fukumoto A., Furukawa T., Kato H., et al. Bioactive bone cement: comparison of apatite and wollastonite containing glass-ceramic, hydrxyapatite and β-tricalcium phosphate fillers on bone-bonding strength. J Biomed Mater Res 42 (1998) 223-237
19. Zhao W., and Chang J. Sol-gel synthesis and in vitro bioactivity of tricalcium silicate powders. Mater Lett 58 (2004) 2350-2353
20. Zhao W.Y., Wang J.Y., Zhai W.Y., Wang Z., and Chang J. The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials 26 (2005) 6113-6121
21. Xu J.L., and Khor K.A. Chemical analysis of silica doped hydroxyapatite biomaterials consolidated by a spark plasma sintering method. J Inorg Biochem 101 (2007) 187-195
22. Thian E.S., Huang J., Best S.M., Barber Z.H., Brooks R.A., Rushton N., et al. The response of osteoblasts to nanocrystalline silicon-substituted hydroxyapatite thin films. Biomaterials 27 (2006) 2692-2698
23. Porter A.E. Nanoscale characterization of the interface between bone and hydroxyapatite implants and the effect of silicon on bone apposition. Micron 37 (2006) 681-688
24. Xynos I.D., Edgar A.J., Buttery L.D., Hench L.L., and Polak J.M. Gene-expression profiling of human osteoblasts following treatment with ionic products of biological 45S5 dissolution. J Biomed Mater Res 55 (2001) 151-157
25. Mirtchi A.A., Lemaitre J., and Terao N. Calcium phosphate cements: study of the β-tricalcium phosphate-monocalcium phosphate system. Biomaterials 10 (1989) 634-638
26. Bohner M., and Baroud G. Injectablity of calcium phosphate pastes. Biomaterials 26 (2005) 1553-1563
27. Khairoun I., Boltong M.G., Driessens F.C.M., and Planell J.A. Some factors controlling the injectability of calcium phosphate bone cements. J Mater Sci Mater Med 9 (1998) 425-428
28. Grover L.M., Knowles J.C., Fleming G.J.P., and Barralet. In vitro ageing of brushite calcium phosphate cement. Biomaterials 24 (2003) 4133-4141
29. Huan Z.G., and Chang J. Novel tricalcium silicate/monocalcium phosphate monohydrate composite bone cement. J Biomed Mater Res Part B Appl Biomater 82 B (2007) 352-359
30. Nurit J., Margerit J., Terol A., and Boudeville P. PH-metric study of the setting reaction of monocalcium phosphate monohydrate/calcium oxide-based cements. J Mater Sci Mater Med 13 (1993) 1007-1014
31. Kokubo T. Surface chemistry of bioactive glass-ceramics. J Non-Crystallogr Solids 120 (1990) 138-151
32. Kokubo T., and Takadama H. How useful is SBF in predicting in vivo bone bioactivity. Biomaterials 27 (2006) 2907-2915
33. ISO/EN 10993-5. Biological evaluation of medical devices - Part 5. Tests for cytotoxicity, in vitro methods: 8.2 tests on extract.
34. Cory A.H., Owen T.C., Barltrop J.A., and Cory J.G. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3 (1991) 207-212
35. Sogo Y., Ito A., Kamo M., Sakurai T., Onuma K., Ichinose N., et al. Hydrolysis and cytocompatibility of zinc-containing α-tricalcium phosphate powder. Mater Sci Eng C 24 (2004) 709-715
36. Xu H.H.K., Carey L.E., Simon C.G., Takagi S., and Chow L.C. Premixed calcium phosphate cements: synthesis, physical properties, and cell cytotoxicity. Dent Mater 23 (2007) 433-441
37. Mauney J.R., Jaquiery C., Volloch V., Heberer M., Martin I., and Kaplan D.L. In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering. Biomaterials 26 (2005) 3173-3185
38. Lowry O.H., Roberts N.R., Wu M., Hixton W.S., and Crawford E.J. The quantitative histochemistry of brain II. Enzyme measurements. J Biol Chem 207 (1954) 19-37
39. Bohner M., Gbureck U., and Barralet J.E. Technological issues for the development of more efficient calcium phosphate bone cement: a critical assessment. Biomaterials 26 (2005) 6423-6429
40. Barralet J.E., Grover L.M., and Gbureck U. Ionic modification of calcium phosphate cement viscosity. Part II. Hypodermic injection and strength improvement of brushite cement. Biomaterials 25 (2004) 2197-2203
41. Lilley K.J., Gbureck U., Knowles J.C., Farrar D.F., and Barralet J.E. Cement from magnesium substituted hydroxyapatite. J Mater Sci Mater Med 16 (2005) 455-460
42. Bohner M. Reactivity of calcium phosphate cements. J Mater Chem 17 (2007) 3980-3986
43. Pietak A.M., Reid J.W., Scott M.J., and Sayer M. Silicon substitution in the calcium phosphate bioceramics. Biomaterials 28 (2007) 4023-4032
44. Wang X.P., Ye J.D., Wang Y.J., and Chen L. Self-setting properties of a β-dicalcium silicate reinforced calcium phosphate cement. J Biomed Mater Res Part B Appl Biomater 82 (2007) 93-99
45. Huan Z.G., and Chang J. Self-setting properties and in vitro bioactivity of calcium sulfate hemihydrate-tricalcium silicate composite bone cements. Acta Biomater 3 (2007) 952-960
46. Kobayashi M., Nakamura T., Shinzato S., Mousa W.F., Nishio K., Ohsawa K., et al. Effect of bioactive filler content on mechanical properties and osteoconductivity of bioactive bone cement. J Biomed Mater Res 46 (1999) 447-457
47. Cabaňas M.V., Rodríguez-Lorenzo L.M., and Vallet-Regí M. Setting behavior and in vitro bioactivity of hydroxyapatite/calcium sulfate cements. Chem Mater 14 (2002) 3550-3555
48. Hench L.L., and West J.K. Biological applications of bioactive glasses. Life Chem Rep 13 (1996) 187-241
49. Marom R., Shur I., Solomon R., and Benayahu D. Characterization of adhesion and differentiation markers of osteogenic marrow stromal cells. J Cell Physiol 202 (2005) 41-48
50. Stucki U., Schmid J., Hammerle C.F., and Lang N.P. Temporal and local appearance of alkaline phosphatase activity in early stages of guided bone regeneration: a descriptive histochemical study in humans. Clin Oral Implant Res 12 (2001) 121-127
51. Reffitt D.M., Ogston N., Jugdaohsingh R., Cheung H.F., Evans B.A., Thompson R.P., et al. Orthosilicic acid stimulates collagen type I synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32 (2003) 127-135
52. Dufrane D., Delloye C., Mckay J., De Aza P.N., De Aza S., Schaneider Y.J., et al. Indirect cytotoxicity evaluation of pseudo wollastonite. J Mater Sci Mater Med 14 (2003) 33-38
53. Sun H.L., Wu C.T., Dai K.R., Chang J., and Tang T.T. Proliferation and osteoblastic differentiation of human bone marrow-derived stromal cells on akermanite-bioactive ceramics. Biomaterials 27 (2006) 5651-5657